Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.085 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |